Completeness of TNM staging of small-cell and non-small-cell lung cancer in the Danish Cancer Registry, 2004-2009

Clinical Epidemiology

Volumn 4, Issue SUPPL.2, 2012, Pages 39-44

  Deleuran, Thomas ^a   Søgaard, Mette ^a,b   Frøslev, Trine ^a   Rasmussen, Torben Riis ^a   Jensen, Henrik Kirstein ^b   Friis, Søren ^c   Olsen, Morten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cancer registers; Cancer staging; Completeness; Lung cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CHILD; CLASSIFICATION ALGORITHM; COMORBIDITY; DENMARK; DISTANT METASTASIS; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; INFANT; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT IDENTIFICATION; PRESCHOOL CHILD; SCHOOL CHILD; TREND STUDY; TUMOR CLASSIFICATION;

EID: 84866713581     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S33315     Document Type: Article

References (24)

1. Danish Board of Health. The Danish Cancer Registry 2010. Copenhagen, Danish Board of Health, 2011. http://www.sst.dk/publ/Publ2011/DAF/Cancer/Cancerregisteret2010.pdf.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917.
3. Danish Board of Health. The Danish Register of Causes of Death 2010. Copenhagen, Danish Board of Health, 2011. http://www.sst.dk/publ/Publ2011/DAF/Doedsaarsagertal2010.pdf.
4. Kuo YW, Jerng JS, Shih JY, Chen KY, Yu CJ, Yang PC. The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma. J Thorac Oncol. 2011;6(2):378-383.
5. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg. 2005;28(5):759-762.
6. Janssen-Heijnen ML, Smulders S, Lemmens VE, Smeenk FW, van Geffen HJ, Coebergh JW. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax. 2004;59(7):602-607.
7. Blanco JA, Toste IS, Alvarez RF, Cuadrado GR, Gonzalvez AM, Martín IJ. Age, comorbidity, treatment decision and prognosis in lung cancer. Age Ageing. 2008;37(6):715-718.
8. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer. 2003;103(6):792-802.
9. Sørensen M, Pijls-Johannesma M, Felip E. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(5 Suppl):120-125.
10. Crinò L, Weder W, van Meerbeeck J, Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(5 Suppl):103-115.
11. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3(1):46-52.
12. Merrill RM, Sloan A, Anderson AE, Ryker K. Unstaged cancer in the United States: a population-based study. BMC Cancer. 2011;11:402.
13. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27-33.
14. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42-45.
15. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. Nov 1997;44(5):535-539.
16. AJCC. Cancer Staging Manual. 6th ed: Springer-Verlag; 2002.
17. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7 Suppl):22-25.
18. Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39(7 Suppl):72-74.
19. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30-33.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
21. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
22. Yu JB, Gross CP, Wilson LD, Smith BD. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009;23(3):288-295.
23. Klassen AC, Curriero F, Kulldorff M, Alberg AJ, Platz EA, Neloms ST. Missing stage and grade in Maryland prostate cancer surveillance data, 1992-1997. Am J Prev Med. 2006;30(2 Suppl):S77-S87.
24. Koroukian SM, Xu F, Beaird H, Diaz M, Murray P, Rose JH. Complexity of care needs and unstaged cancer in elders: a population-based study. Cancer Detect Prev. 2007;31(3):199-206.